Bristol-Myers Squibb | BMY - Capitale Ordinario





Capitale Ordinario Cambiamento Data
AbbVie USD 1.77B 1.75B 2025-06
Abbott USD 1.74B 2.94M 2026-03
ALKERMES USD 167.54M 1.08M 2026-06
Amgen USD 541M 1000K 2026-06
AstraZeneca USD 1.55B 44K 2026-06
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Coherus Biosciences USD 121.16M 4.92M 2025-12
Drreddys Laboratories INR 832.69M 123K 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
J&J USD 2.41B 1.35M 2026-03
Medtronic USD 1.28B 130K 2026-06
Merck USD 2.47B 4.93M 2026-03
Novartis USD 1.9B 7.38M 2026-06
Novo Nordisk DKK 4.43B 13.25M 2026-06
Perrigo USD 138.1M 500K 2026-03
Pfizer USD 5.7B 0 2026-06
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 47.37M 53K 2026-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Sanofi EUR 1.21B 8.25M 2026-03
Sanofi EUR 1.2B 16.88M 2026-03
United Therapeutics USD 42.68M 521K 2026-06
Zoetis USD 414.15M 6.19M 2026-06